Our first edition of 2022 focuses on Healthcare and Life Sciences. It is a sector that will once again have the spotlight on it this year as we continue to tackle COVID-19 and its subsequent variants. While the pandemic continues to challenge the sector, governments across the region forge ahead with their plans to expand and upgrade healthcare systems and develop robust world-class healthcare infrastructure.
For the region, healthcare is a vital pillar in diversifying its economies, both locally and as medical tourism hubs. To underpin this, healthcare authorities across the region continue to implement frameworks and regulations that provide structure and accountability.
In this edition, you have unique access to great insights and expert commentary on a number of pertinent healthcare regulatory developments. You will find a topical mix of articles; for example, our lawyers discuss vaccines and returning to work during the pandemic. They take you through several other areas, including stem cell research in Bahrain, clinical research laws in Egypt, and Saudi medical device and pharmaceutical laws.Take a read of the edition
Ribal is an Associate for Al Tamimi’s Banking & Finance department in Riyadh. Prior to joining Al Tamimi, Ribal worked for almost 4 years at a tier 1 full service law firm in Pakistan (Haidermota & Co.), where he advised on various corporate, commercial and banking & finance matters. In particular, such matters include advising on the development and/or financing of energy and infrastructure projects, banking & finance, public-private partnerships, foreign investments, mergers & acquisitions, joint ventures and anti-trust issues.
2016 – Master of Laws (LL.M), Financial Regulation and Compliance, BPP University, London
2014 – Postgraduate Diploma, International Legal Practice (LPC), University of Law, London
2011 – Bachelor of Laws (LL.B)(Hons.), University of London
Enrolled as an Advocate of the High Courts in Pakistan